NEXThaler Fully Automatic Dry Powder Asthma Inhaler

Cambridge Consultants is touting a new dry powder inhaler that the firm helped to design for Chiesi, an Italian pharmaceutical company. The NEXThaler, as the device is called, automates dosing and delivery of asthma medication to make it easy and nearly mindless for patients to stay on their regimen.....

Continue reading at medgadget.com



Mission Pharmacal revamps pediatric asthma medicine

Mission Pharmacal Co. has reformulated its Prednisolone Sodium Phosphate Oral Solution for patients with severe asthma by giving it a better taste.
The drug manufacturer has created a new liquid oral solution with a grape taste for pediatric patients. Company officials say for years, physicians have prescribed Prednisolone in a 15 mg/5 mL dosage as a rescue medicine to treat severe asthma attacks. However, because of its unpleasant taste, young patients have often thrown up after taking it.....

Information at bizjournals.com



Genetic Variants and Wheezing Put Kids At Risk For Asthma

Almost every toddler will sniffle through a cold by the time they are three, but if they wheeze while they’re sick, they may be at higher risk of developing asthma.
Previous research found that wheezing-related illnesses can increase a child’s risk for developing asthma, and other studies connected certain genetic factors to this heightened tendency to wheeze. In a new study published in the New England Journal of Medicine, researchers connected the two and found that 90% of three-year-olds with a combination of specific genes and a particular wheezing illness were diagnosed with asthma by the age of 6.

Read more: healthland.time.com